Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Institute of Mental Health (NIMH) |
---|---|
Information provided by: | National Institute of Mental Health (NIMH) |
ClinicalTrials.gov Identifier: | NCT00055393 |
This study will determine whether the drug bupropion is an effective treatment for Pathological Gambling.
Condition | Intervention |
---|---|
Gambling |
Drug: Bupropion |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study |
Official Title: | Bupropion Versus Placebo in the Treatment of Pathological Gambling |
Estimated Enrollment: | 80 |
Study Start Date: | July 2002 |
Study Completion Date: | April 2006 |
Estimated Primary Completion Date: | May 2005 (Final data collection date for primary outcome measure) |
As gambling opportunities proliferate, PG has become a major health concern. Despite its importance, few treatment options with proven efficacy exist. This study will attempt to identify an effective treatment for PG.
Participants are randomly assigned to receive either bupropion or placebo for 12 weeks. Participants are assessed at baseline and at Weeks 2, 3, 4, 5, 6, 8, 10, and 12. Self administered questionnaires and interviews are used to assess participants. Follow-up assessments are made 1, 3, and 6 months after study completion.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Study ID Numbers: | R21 MH63289, DSIR AT-AS |
Study First Received: | February 28, 2003 |
Last Updated: | February 15, 2008 |
ClinicalTrials.gov Identifier: | NCT00055393 |
Health Authority: | United States: Federal Government |
Impulse Control Disorders Dopamine Gambling Mental Disorders Bupropion |
Dopamine Uptake Inhibitors Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Therapeutic Uses Physiological Effects of Drugs |
Psychotropic Drugs Dopamine Agents Antidepressive Agents, Second-Generation Central Nervous System Agents Pharmacologic Actions Antidepressive Agents |